However, EAI045 was able to inhibit the proliferation of cell lines and tumor growth of models expressing L858R/T790M- and L858R/T790M/C797S-EGFR, only when combined with dimerization blocking antibodies, like cetuximab [99]. The gene discussed is EGFR; the disease is neoplasm.